Shopping Cart

Your shopping cart is currently empty

Asenapine Maleate

Name: Asenapine Maleate
Brand: TargetMol
SKU: T1951
Price: 30 USD
Availability: InStock
Rating: 5 (10 reviews)

Copy Product Info

🥰Excellent

Catalog No. T1951Cas No. 85650-56-2

Alias Org 5222 maleate, Org 5222

Asenapine Maleate (Org 5222 maleate) is a second generation (atypical) antipsychotic agent that is taken sublingually and used in the treatment of schizophrenia and manic or mixed episodes associated with bipolar 1 disorder. Asenapine is associated with a low rate of transient and mild serum aminotransferase elevations during therapy but has not been linked to instances of clinically apparent acute liver injury.

Asenapine Maleate

Copy Product Info

🥰Excellent

Purity: 99.28%

Catalog No. T1951Alias Org 5222 maleate, Org 5222Cas No. 85650-56-2

Pack Size	Price	USA Warehouse	Global Warehouse
5 mg	$30	In Stock	In Stock
10 mg	$45	In Stock	In Stock
25 mg	$68	In Stock	In Stock
50 mg	$92	In Stock	In Stock
100 mg	$130	In Stock	In Stock
500 mg	$372	In Stock	In Stock
1 mL x 10 mM (in DMSO)	$48	In Stock	In Stock

Add to Cart

Add to Quotation

In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Questions

Batch Information

Select Batch

Purity:99.28%

Appearance:Solid

Color:White

Resource Download

COA HNMR LCMS

Product Introduction

Bioactivity

Description	Asenapine Maleate (Org 5222 maleate) is a second generation (atypical) antipsychotic agent that is taken sublingually and used in the treatment of schizophrenia and manic or mixed episodes associated with bipolar 1 disorder. Asenapine is associated with a low rate of transient and mild serum aminotransferase elevations during therapy but has not been linked to instances of clinically apparent acute liver injury.
Targets&IC50	5-HT2A:10.15(pKi), D3 receptor:0.42 nM (Ki), D4 Receptor:1.1 nM (Ki), 5-HT7:9.94(pKi), 5-HT2B:9.75(pKi), 5-HT2C:10.46(pKi), D2 Receptor:1.3 nM (Ki), sPLA2:2.5 nM (Ki), 5-HT6:9.6(pKi)
In vitro	Asenapine (0.01 mg/kg, i.v.) preferentially increased dopamine outflow in the shell compared to the nucleus accumbens (NAc) core, with no difference observed at a higher dosage (0.05 mg/kg, i.v.). Asenapine significantly enhanced the response to NMDA in pyramidal cells within the medial prefrontal cortex. In freely moving rats, Asenapine (0.05-0.2 mg/kg, subcutaneous injection) induced dose-dependent conditioned avoidance response (CAR) inhibition (without recording escape failures) and did not induce cataleptic fainting. Moreover, Asenapine (0.05-0.2 mg/kg, subcutaneous injection) increased dopamine outflow in both the medial prefrontal cortex and the nucleus accumbens in rats.
In vivo	Asenapine demonstrates a higher affinity for 5-HT 2C, 5-HT 2A, 5-HT 2B, 5-HT 7, 5-HT 6, alpha2B, and D3 receptors compared to its affinity for D2 receptors, indicating a closer interaction with these targets at therapeutic doses. Asenapine is an effective antagonist for a range of receptors, including 5-HT 1A (7.4), 5-HT 1B (8.1), 5-HT 2A (9.0), 5-HT 2B (9.3), 5-HT 2C (9.0), 5-HT 6 (8.0), 5-HT 7 (8.5), D2 (9.1), D3 (9.1), alpha2A (7.3), alpha2B (8.3), alpha2C (6.8), and H 1 receptors (8.4), as indicated by their respective pKB values.
Kinase Assay	In vitro kinase activity: GST-FAK in vitro kinase activity is measured and compared to His-tagged FAK 411–686 using the K-LISA screening kit and poly(Glu:Tyr) (4:1) copolymer as a substrate immobilized on microtiter plates. IC50 values are determined with various concentrations of test compounds in a buffer containing 50 μM ATP and 10 mM MnCl2, 50 mM HEPES (pH 7.5), 25 mM NaCl, 0.01% BSA, and 0.1 mM Na orthovanadate for 5 min at room temperature. Serial diluted compounds are tested in triplicate. Substrate phosphorylation is measured using horseradish peroxidase-conjugated anti-pTyr antibodies with spetrophotometric color quantitation. IC50 values are determined using the Hill-Slope Model. Kinase selectivity profiling is performed by using the KinaseProfiler service.
Synonyms	Org 5222 maleate, Org 5222

Chemical Properties

Molecular Weight	401.84
Formula	C₂₁H₂₀ClNO₅
Cas No.	85650-56-2
Smiles	OC(=O)\C=C/C(O)=O.[H][C@@]12CN(C)C[C@@]1([H])c1cc(Cl)ccc1Oc1ccccc21
Relative Density.	no data available

Storage & Solubility Information

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Solubility Information

H2O: < 1 mg/mL (insoluble or slightly soluble)

DMSO: 60 mg/mL (149.31 mM), Sonication is recommended.

Ethanol: < 1 mg/mL (insoluble or slightly soluble)

In Vivo Formulation

10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (4.98 mM), Sonication is recommended.

Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.

Solution Preparation Table

DMSO

	1mg	5mg	10mg	50mg
1 mM	2.4886 mL	12.4428 mL	24.8855 mL	124.4276 mL
5 mM	0.4977 mL	2.4886 mL	4.9771 mL	24.8855 mL
10 mM	0.2489 mL	1.2443 mL	2.4886 mL	12.4428 mL
20 mM	0.1244 mL	0.6221 mL	1.2443 mL	6.2214 mL
50 mM	0.0498 mL	0.2489 mL	0.4977 mL	2.4886 mL
100 mM	0.0249 mL	0.1244 mL	0.2489 mL	1.2443 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:

For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments

and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent

10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH₂O , the resulting working solution concentration would be 2 mg/mL.

Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSO TargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSO TargetMol | reagent stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH₂O TargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.

All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc